GenePOC announces it received 510(k) clearance from the US Food and Drug Administration to market its first molecular assay to detect Group B Streptococcus and for the revogene molecular diagnostics instrument. Read the Press Release.
This author has yet to write their bio.Meanwhile lets just say that we are proud firstname.lastname@example.org contributed a whooping 4 entries.
Entries by email@example.com
GenePOC will participate in the ASM (American Society for Microbiology) from June 1 to 5, in New Orleans, Louisiana, USA. Come visit our booth #3004, and discover the new revogene system for cost-effective, rapid, and accurate molecular detection of infectious diseases at Point-of-Care.
Contact UsIf you have questions, comments or need more information concerning GenePOC, talk to one of our customer service representatives. We will be pleased to assist you.
Write360 Rue Franquet, Porte 3
Canada G1P 4N3
Call1 (418) 650-3535
Monday to Friday
8:00 a.m. to 5:00 p.m. EST